Catalina Capital Group LLC Makes New Investment in Connect Biopharma Holdings Limited (NASDAQ:CNTB)

Catalina Capital Group LLC purchased a new stake in shares of Connect Biopharma Holdings Limited (NASDAQ:CNTB) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 47,867 shares of the company’s stock, valued at approximately $66,000.

Separately, BML Capital Management LLC raised its stake in Connect Biopharma by 2.4% in the third quarter. BML Capital Management LLC now owns 2,093,232 shares of the company’s stock valued at $3,014,000 after purchasing an additional 49,984 shares in the last quarter. Institutional investors and hedge funds own 58.72% of the company’s stock.

Connect Biopharma Price Performance

CNTB stock opened at $1.00 on Wednesday. The firm has a 50 day simple moving average of $1.08 and a two-hundred day simple moving average of $1.16. Connect Biopharma Holdings Limited has a one year low of $0.91 and a one year high of $2.66.

About Connect Biopharma

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets.